STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE II PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE II PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE II PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation course tested to ease side effects after prostate surgery
Disease control CompletedThis study tested whether a shorter, more intense course of radiation (given over 5 weeks) was as effective and caused fewer side effects than the standard longer course (over 7 weeks) for men who had surgery for prostate cancer. Nearly 300 men participated and were randomly assi…
Matched conditions: STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 02, 2026 03:57 UTC
-
Study aims to stop prostate Cancer's return with Triple-Threat therapy
Disease control CompletedThis study tested whether adding a chemotherapy drug (docetaxel) to the standard post-surgery treatment of hormone therapy and radiation could better prevent prostate cancer from coming back. It involved over 600 men who had surgery for prostate cancer but were at high risk of re…
Matched conditions: STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 02, 2026 03:56 UTC